Cerebras
CBRS
$184.52
+6.89%
Cerebras Systems Inc. is an AI company that designs and builds the world's fastest AI infrastructure for training and inference, including the largest semiconductor ever made and the systems to power, cool, and feed it data. As a niche player in the AI hardware market, Cerebras differentiates itself with its wafer-scale engine technology, which offers a unique alternative to traditional GPU-based systems from competitors like Nvidia. The company has recently gone public (IPO on May 14, 2026) and is attracting significant investor attention due to its rapid revenue growth, major partnerships with OpenAI and AWS, and a substantial $25 billion backlog, but it also faces scrutiny over its high valuation, negative profitability, and volatile stock performance. The current narrative centers on whether Cerebras can capitalize on the AI infrastructure boom and achieve sustainable profitability while navigating intense competition and execution risks.…
CBRS
Cerebras
$184.52
Related headlines
Investment Opinion: Should I buy CBRS Today?
Rating: Hold. The consensus 'Strong Buy' and average target of $291.64 suggest upside, but the extreme valuation and unprofitability warrant caution. The thesis is that Cerebras' growth and backlog justify a premium, but the current price already reflects high expectations.
Sign up to view all
CBRS 12-Month Price Forecast
Cerebras is a high-growth but high-risk AI infrastructure play. The revenue growth and backlog are exceptional, but the valuation leaves no room for error. The AI assessment is neutral because the growth potential is offset by the extreme PS ratio and competitive threats. I would upgrade to bullish if the company shows sustained profitability or if the stock price corrects to a more reasonable valuation, and downgrade to bearish if revenue growth decelerates below 50% or if a major customer is lost.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cerebras's 12-month outlook, with a consensus price target around $291.64 and implied upside of +58.0% versus the current price.
Average Target
$291.64
0 analysts
Implied Upside
+58.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$209 - $330
Analyst target range
The wide target range of $209 to $330 (a spread of $121) indicates high uncertainty about the company's future performance, which is typical for a newly public company in a high-growth but competitive industry. The low target of $209 likely prices in risks such as margin compression, competitive losses to Nvidia, or slower-than-expected adoption of its technology. The high target of $330 assumes that Cerebras will successfully execute on its $25 billion backlog, expand its partnerships with OpenAI and AWS, and achieve significant market share in the AI infrastructure market. The consensus 'Strong Buy' rating and the fact that all recent ratings have been positive suggest that analysts are confident in the company's long-term potential, but the wide target range highlights the speculative nature of the stock. Insufficient analyst coverage is not an issue here, as 11 analysts provide adequate coverage for a company of this size, but the recent IPO date means that coverage may evolve as more data becomes available.
Drowning in data?
Find the real signal!
Bulls vs Bears: CBRS Investment Factors
Cerebras presents a classic high-risk, high-reward opportunity. The bull case rests on explosive revenue growth, a massive backlog, and improving margins, while the bear case centers on an extreme valuation and persistent losses. Currently, the bearish evidence is stronger given the stock's 53.6% decline from its high and the 131x PS ratio, which leaves little room for error. The pivotal tension is whether Cerebras can convert its $25B backlog into profitable revenue fast enough to justify its valuation, or if competitive and execution risks will trigger a further de-rating.
Bullish
- Explosive Revenue Growth: Q1 2026 revenue surged 94.35% YoY to $193.4M, with sequential growth of 12.8% from Q4 2025. This acceleration demonstrates strong market demand for Cerebras' wafer-scale AI systems.
- Massive $25B Backlog: The company holds a $25 billion backlog, providing multi-year revenue visibility. Partnerships with OpenAI and AWS anchor this demand, reducing near-term revenue uncertainty.
- Improving Profitability Trajectory: Net loss narrowed to $14.0M in Q1 2026 from $25.6M in Q4 2025 and $105.7M in Q4 2024. Gross margin expanded to 44.56% from 40.97% sequentially, indicating scale benefits.
- Strong Analyst Conviction: Analysts rate CBRS a 'Strong Buy' with an average target of $291.64, implying 62.8% upside from the current price of $179.08. The high target of $330 suggests even greater potential.
Bearish
- Extreme Valuation Premium: PS ratio of 131.28 is over 13x the semiconductor industry average of ~10x. EV/Sales of 55.7 and forward PE of 140.6 imply the market prices in flawless execution for years.
- Persistent Unprofitability: Despite narrowing losses, the company still posted a net loss of $14.0M in Q1 2026. Operating margin remains deeply negative at -7.77%, and TTM net income is negative, raising doubts about near-term profitability.
- Post-IPO Downtrend: The stock has fallen 53.6% from its 52-week high of $386.34 to $179.08, with a max drawdown of -45.83%. This sustained decline reflects waning investor enthusiasm and high volatility.
- Competitive Pressure from Nvidia: Nvidia dominates the AI chip market with an established ecosystem. Cerebras' wafer-scale technology is unproven at scale, and any major customer loss to Nvidia could severely impact growth.
CBRS Technical Analysis
Cerebras has been in a clear downtrend since its IPO, with the stock price falling from an opening high of $386.34 to a current price of $179.08, a decline of 53.6% from its 52-week high. The stock is currently trading at 46.4% of its 52-week range (calculated as (179.08 - 160.81) / (386.34 - 160.81) = 0.464), indicating it is near the lower end of its range, which suggests a potential value opportunity or a falling knife depending on fundamental support. The 1-year price change is not available since the stock has only been public for about 3.5 months, but the price action since IPO shows a sustained downtrend with periodic bounces, reflecting high volatility and uncertainty.
Beta
—
—
Max Drawdown
-45.8%
Largest decline past year
52-Week Range
$161-$386
Price range past year
Annual Return
—
Cumulative gain past year
| Period | CBRS Return | S&P 500 |
|---|---|---|
| 1m | -16.1% | +1.0% |
| 3m | -14.3% | +1.1% |
| 6m | — | +13.8% |
| 1y | — | +19.5% |
| ytd | — | +12.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CBRS Fundamental Analysis
Cerebras has demonstrated exceptional revenue growth, with Q1 2026 revenue of $193.4 million, representing a 94.35% year-over-year increase from $99.5 million in Q1 2025. This growth is accelerating, as sequential revenue increased from $171.4 million in Q4 2025 to $193.4 million in Q1 2026, a 12.8% quarter-over-quarter growth. The company's gross margin improved to 44.56% in Q1 2026, up from 40.97% in Q4 2025, indicating better cost management and scale. However, the company remains unprofitable, with a net loss of $14.0 million in Q1 2026, though this loss is narrowing compared to the $25.6 million loss in Q4 2025 and the $105.7 million loss in Q4 2024, showing a clear trajectory toward profitability.
Quarterly Revenue
$193406000.0B
2026-03
Revenue YoY Growth
+94.3%
YoY Comparison
Gross Margin
44.6%
Latest Quarter
Free Cash Flow
$145070500.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CBRS Overvalued?
Given that Cerebras has negative trailing twelve-month net income (TTM net income is -$14.0 million for Q1 2026, but with a positive EPS of $0.0035 due to a one-time gain in Q2 2025, the trailing PE is 758.7, which is not meaningful), I will use the price-to-sales (PS) ratio as the primary valuation metric. The current PS ratio is 131.28, which is extremely high compared to the semiconductor industry average of around 10x, indicating a significant premium. The forward PE ratio is 140.6, which implies that the market expects substantial earnings growth, but the gap between trailing and forward PE suggests optimistic expectations. The EV/Sales ratio of 55.7 is also elevated, reflecting the market's high growth expectations for the company.
PE
758.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
848.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are substantial. The company's negative operating margin of -7.77% and net loss of $14.0M in Q1 2026 indicate ongoing cash burn, though free cash flow turned positive at $145.1M TTM. The debt-to-equity ratio of -0.45 is unusual, reflecting negative equity, which could signal financial fragility. With a current ratio of 2.15, liquidity is adequate, but the reliance on continued growth to justify the 131x PS ratio leaves no margin for error. Any slowdown in revenue growth or margin deterioration could trigger a sharp valuation correction.
FAQ
The key risks are: 1) Financial risk: The company is unprofitable with a net loss of $14.0M in Q1 2026, and negative equity (debt-to-equity of -0.45) could strain future financing. 2) Competitive risk: Nvidia's dominance in AI chips could limit Cerebras' market share. 3) Valuation risk: The PS ratio of 131.28 is extremely high, and any growth slowdown could trigger a de-rating. 4) Company-specific risk: The stock is highly volatile, with a max drawdown of -45.83% since IPO, and the $25B backlog may not convert as quickly as expected.
The 12-month forecast is mixed. The bull case (25% probability) sees the stock reaching $291.64 to $330, driven by strong execution and margin expansion. The base case (45% probability) targets $209 to $291.64, assuming continued growth but with valuation pressure. The bear case (30% probability) could see the stock fall to $160.81 to $209 if growth decelerates or competitive pressures mount. The most likely scenario is the base case, with the stock trading near the analyst average target of $291.64, but the wide range reflects high uncertainty.
CBRS is significantly overvalued relative to its peers. The PS ratio of 131.28 is over 13x the semiconductor industry average of ~10x, and the forward PE of 140.6 implies extremely optimistic earnings expectations. The EV/Sales ratio of 55.7 is also elevated. This valuation suggests the market expects Cerebras to grow into its price, but any disappointment could lead to a sharp correction. Compared to its own history, the stock has fallen 53.6% from its high, but it still trades at a premium that leaves little room for error.
CBRS is a high-risk, high-reward stock. The analyst consensus is 'Strong Buy' with an average target of $291.64, implying 62.8% upside from the current price of $179.08. However, the PS ratio of 131.28 is extremely high, and the company is still unprofitable. It could be a good buy for investors who believe in the AI infrastructure boom and can tolerate high volatility, but it is not suitable for risk-averse investors. The biggest downside risk is a further decline to the 52-week low of $160.81, which would represent a 10.2% loss from the current price.
CBRS is more suitable for long-term investors with a high risk tolerance. The company is in a high-growth phase, with revenue growing 94.35% YoY, but it is not yet profitable. The stock is highly volatile, with a beta likely above 2, making it unsuitable for short-term trading unless you are an experienced trader. A minimum holding period of 3-5 years is recommended to allow the company to execute on its $25B backlog and achieve profitability. For short-term investors, the stock's volatility and post-IPO downtrend present significant risks.